1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsResearch on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) is sponsored by National Institute on Aging (NIA), NIH. This opportunity supports mission-aligned projects and measurable outcomes.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-AG-25-023: Notice of Early Expiration of PAR-25-331, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)" Notice of Early Expiration of PAR-25-331, "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)" December 30, 2024 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional).
See NOFO PAR-25-331 . This Notice informs applicants that, effective immediately, PAR-25-331 , Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) is expired. No further applications will be accepted for PAR-25-331 .
However, applicants can submit an unsolicited grant application to any of the NIH Parent NOFOs . For more information regarding PAR-25-331 , applicants may refer to NIAs web page . Please direct all inquiries to: NIA Scientific Program Contact Weekly TOC for this Announcement NIH...
Turning Discovery Into Health ®
According to the current listing, eligibility includes: Eligible institutions and investigators in biomedical/behavioral research. Confirm the full requirements in the official notice before applying.
Applications for Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) are due November 17, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) is funded by National Institute on Aging (NIA), NIH. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article